Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Glioblastoma Anaplastic Astrocytoma

A Pharm-Olam Case Study

Read the Case Study

About the Case Study

Pharm-Olam is currently partnering with a sponsor company in the development of a treatment for Glioblastoma / Anaplastic Astrocytoma. This type of brain tumor has very few available therapies, so this study’s goal is to assist in potentially identifying additional effective treatment options.

Sites & Locations:
60 across North America, Western Europe, and the Middle East

Services Provided:

  • Regulatory
  • Monitoring
  • Project Management
  • Quality Assurance

 

How can we help you create a healthier world?

Talk to one of our experts today.

Please choose one.

Contact Us